Skip to main content
SpringerLink
Log in

Critical Acute Akinesia in Parkinson’s Disease Patients Concomitant with Additional Precipitating Factors Other Than Treatment Withdrawal: A Possible Lethal Complication

  • Conference paper
Advances in Alzheimer’s and Parkinson’s Disease

Part of the book series: Advances in Behavioral Biology ((ABBI,volume 57))

  • 2020 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology 2005;64:1162–1169.

    PubMed  Google Scholar 

  2. Kipps CM, Fung VSC, Grattan-Smith P, de Moore GM, Morris JGL. Movement disorders emergencies. Mov Disord doi: 10.1002/mds.20325.

    Google Scholar 

  3. Friedman JH, Feinberg SS, Feldman RC. Neuroleptic malignant-like syndrome due to l-dopa withdrawal. Ann Neurol 1984;16:126.

    Google Scholar 

  4. Granner MA, Wooten GF. Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Semin Neurol 1991;11:228–235.

    Article  PubMed  CAS  Google Scholar 

  5. Takubo H, Harada T, Hashimoto T, et al, A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 2003;9:S31–S41.

    Article  PubMed  Google Scholar 

  6. Quinn NP. Classification of fluctuations in patients with Parkinson's disease. Neurology 1998;51(Suppl 2):S25–S29.

    PubMed  CAS  Google Scholar 

  7. Stacy M, Factor S. Rapid treatment of “off” episodes: will this change Parkinson disease therapy? Neurology 2004;62(Suppl 4):S1–S2.

    Google Scholar 

  8. Danielczyk W. Die Behandlung von akinetischen Krisen. Med Welt 1973;24:1278–1282.

    PubMed  CAS  Google Scholar 

  9. Muschard G, Völler GW. Wirksamkeit von Amantadinsulfat als Infusionslösung bei der Behandlung des Parkinsons Sindroms. Med Welt 1973;24:183–184.

    PubMed  CAS  Google Scholar 

  10. Oppel F, Klaes H. Die Amantadin-Infusionen in der akuten Behandlung der Morbus Parkinson. Klinikarzt 1981;10:559–565.

    Google Scholar 

  11. Deutsche Gesellschaft fúr Neurologie: Leitlinien-Parkinson-Syndrome; 4,3,4,2 Akinetische Krise. http://www.dgn.org/168.0htlm#926.

  12. Tanner CM, Goetz CG, Klawans HL. Autonomic nervous system disorders. In: Koller WC (ed) Handbook of Parkinson's Disease. Marcel Dekker, New York, 1987, pp 161–163.

    Google Scholar 

  13. Danielczyk W. Twenty-five years of amantadine therapy in Parkinson's disease. J Neural Transm Suppl 1995;46:399–409.

    PubMed  CAS  Google Scholar 

  14. Shalev A, Hermesh H, Munitz H. Mortality from neuroleptic malignant syndrome. J Clin Psychiatry 1989;50:18–25.

    PubMed  CAS  Google Scholar 

  15. McKeith I, Misumann U. Dementia with Lewy bodies and Parkinson's disease. Parkinsonism Relat Disord 2004;10(Suppl 1):S15–S18.

    Article  PubMed  Google Scholar 

  16. Dickson DW. Neuropathology of Parkinsonian disorders. In: Jankovic J, Tolosa E (eds) Parkinson's Disease and Movement Disorders, 4th ed. Lippincott Williams & Wilkins, Philadelphia, 2002, pp 256–269.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurophysiopathology, Movement Disorders Center, Department of Oncology and Neuroscience, University “G.D’ Annunzio” Chieti-Pescara, and Aging Research Center, Ce.S.I., “Gabriele D’ Annunzio” University Foundation, Chieti-Pescara, Ospedale Civile di Pescara, Italy

    Marco Onofrj

Authors
  1. Marco Onofrj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Astrid Thomas
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Israel Institute for Biological Research IIBR, Ness-Ziona, Israel

    Abraham Fisher

  2. Universitá degli Studi di Brescia, 25124 Brescia, Italy

    Maurizio Memo

  3. Universitá La Sapienze Roma, 86077 Pozilli, Isernia, Italy

    Fabrizio Stocchi

  4. Department of Pharmacology, Loyola University Stritch School of Medicine, Maywood, IL 60153-5589, USA

    Israel Hanin

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this paper

Cite this paper

Onofrj, M., Thomas, A. (2008). Critical Acute Akinesia in Parkinson’s Disease Patients Concomitant with Additional Precipitating Factors Other Than Treatment Withdrawal: A Possible Lethal Complication. In: Fisher, A., Memo, M., Stocchi, F., Hanin, I. (eds) Advances in Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 57. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-72076-0_5

Download citation

Publish with us

Policies and ethics

Search

Navigation